#
$
% !
"%
!
!"
"
& !!
Appendix
152
Table 1. Demographics and characteristics of 2808 ERCP procedures
Variable Procedures
N = 2808 (% of total)
Responders N = 1477 (% within each variable)
Non-Responder N = 1331 (% within each variable)
value*
Sex
",&
&-",&
/31&0/13&%
Age-groups
8&"12
8&"12
8&"12
8&"12
8&"12
ASA score < 0.001
/31&0/13&%
Procedure time** 0.004
-*.43&2
-*.43&2
-*.43&2
-*.43&2
/31&0/13&%
Procedure***
0)*.$3&1/3/-8/'3)&#*,&%4$3 < 0.001
!1&"3-&.3/' 2 < 0.001
*,"3"3*/./'3)&#*,&%4$3 ,"$&-&.3/'23&.3*.3)& 0.005 ,"$&-&.3/'2&,'&70".%*.(23&.3 7$)".(&/'23&.3*.3)& 0.004
&-/5",/'23&.3/'3)&
!"+*.(20&$*-&.'1/-3)&
-&1(&.$8
1&$4320)*.$3&1/3/-8 4*%&6*1&'/1$"..4,"3*/.
5",4&2"00,83/$/-0"1*2/.2#&36&&.1&20/.%&12".%./.1&20/.%&12
&%*".01/$&%41&3*-&6"2-*.43&2
&5&1",3)&1"0&43*$01/$&%41&2-"8)"5&#&&.0&1'/1-&%%41*.("2*.(,&
01/$&%41&
Table 2. Evaluation of risk for moderate to severe pain during the ERCP procedure by a multivariable regression analysis
Risk factors* n/N** value Adjusted OR 95% CI for OR
Gender
(" -"#"-"* "
")(" < 0.001
Procedure time < 0.001
)&*0/". -"#"-"* "
)&*0/". 0.078
)&*0/". < 0.001
)&*0/". 0.009
Biliary EPT performed
+ -"#"-"* "
". 0.013
%"."!/&+*-"$&)"*&* (0!&*$/%" +)&*"!+-.&*$("0."+#
)&!3+()!&3",)*!,"/%&!&*"*!%+.,&/( 1"-"(.+
&*!","*!"*/-&.'# /+-.#+-,&*!0-&*$/%",-+ "!0-"
-+,+-/&+* +-!&*$/+ /"$+-2 .".&* (0!"!&**(2.".
154Table 3. Evaluation of risk factors for moderate to severe pain after the ERCP
procedure by multivariable regression analysis
Risk factors* n/N value Adjusted OR 95% CI for OR
Gender
& + ! + (
'& < 0.001
Age group < 0.001
1 +, + ! + (
1 +,
1 +,
1 +, 0.041
1 +, 0.016
Hospital category 0.010
($/ +,$-1#),*$-& + ! + ( (-+&#),*$-& 0.003
( +&)''.($-1#),*$-&
Metal stent
) + ! + (
, 0.001
Biliary pre-cut
) + ! + (
, 0.007
Guide-wire use
) + ! + (
, 0.007
Post-ERCP pancreatitis
) + ! + (
, < 0.001 3
Post-ERCP cholangitis
) + ! + (
, < 0.001
# , -$)(+ "$' ($(&.$("-# )'$( )+,$("& ., )!
'$2)&'$2 *'(* -#$$( 0,($( * ( (-+$,%!-)+!)+*$(!- +-#
*+) .+
